Telomere Integrity, Epigenetic Aging, And Genetic Burden Shape Biological Aging Trajectories In Idiopathic Pulmonary Fibrosis
Our bodies age at different rates, and this “biological age” can significantly impact our health, especially in conditions like idiopathic pulmonary fibrosis (IPF), a chronic lung disease where lung tissue becomes scarred. Recent research sheds light on how various factors contribute to this accelerated aging in IPF patients.
Scientists investigated several key indicators of biological aging. They looked at telomere length, which are protective caps at the ends of our chromosomes that naturally shorten as we age. They also examined “epigenetic aging,” which refers to changes in how our genes are expressed without altering the underlying DNA sequence itself. Finally, they considered an individual’s genetic makeup, specifically looking at inherited predispositions.
The findings suggest that these elements are not isolated but work together to shape how IPF progresses. For instance, the initial length of telomeres and the duration of treatment played a role in how telomere length changed over time. Different medications used to treat IPF also had varying effects on these telomere changes. While some measures of epigenetic aging increased with chronological age, others remained stable or even improved with treatment, particularly one specific “epigenetic clock” that proved highly responsive to therapy.
Furthermore, the study confirmed that certain genetic variations are more common in IPF patients, and a higher burden of these genetic factors was linked to poorer lung function. By combining information about telomere health, epigenetic changes, and genetic predispositions, doctors could potentially better predict the course of IPF and tailor treatments more effectively. This integrated approach offers a promising path toward more personalized medicine for this challenging disease.
Source: link to paper